S. Goineau et al., Increased sensitivity of vascular smooth muscle to nitric oxide in dilatedcardiomyopathy of syrian hamsters (Bio TO-2 strain), J CARDIO PH, 37(3), 2001, pp. 290-300
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
We assessed the evolution with time of the responsiveness of three vascular
beds in dilated cardiomyopathic hamsters of the Bio TO-2 strain. Eight car
diomyopathic hamsters and 8 control hamsters were investigated at 180 and 3
00 days of age. Thoracic aorta and mesenteric and renal artery rings were s
tudied in isolated organ baths. Cumulative concentration-response relations
to phenylephrine, acetylcholine, sodium nitroprusside, and angiotensin II
were established for each ring. Maximum effect (E-max) and concentration in
ducing 50% of E-max (EC50) were determined from each concentration-response
curve and pD(2) was calculated as -log(EC50). Compared with control hamste
rs, in cardiomyopathic hamsters, E-max of phenylephrine was not modified in
aorta, whereas it was significantly lower in mesenteric (-6% and -33% at 1
80 and 300 days, respectively) and renal (-17% and -24%) arteries. E-max of
acetylcholine was significantly higher in aorta (+57% and +30%), mesenteri
c (+42% and +34%), and renal (+168% and +70%) arteries. E-max of sodium nit
roprusside was significantly higher in aorta (+26% and +16%) and tended to
be higher in mesenteric (+25% and +23%) and renal (+27% and +10%) arteries.
E-max of angiotensin II was not modified in aorta and tended to be lower i
n mesenteric artery at 300 days. The pD(2) of phenylephrine was significant
ly increased in aorta and the pot of sodium nitroprusside was significantly
increased in aorta and renal artery. In conclusion, in dilated cardiomyopa
thic hamsters, endothelium-dependent and -independent vasodilations are enh
anced early, demonstrating increased sensitivity of vascular smooth muscle
to nitric oxide. This abnormality may be involved in the decreased responsi
veness to phenylephrine and angiotensin II.